|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets held for sale - discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation and amortization of $582,286 and $565,119 | ||||||||||||||||||||
| Patient service equipment and other fixed assets, net of accumulated depreciation and amortization of $196,257 and $207,595 | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Noncurrent assets held for sale - discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and (deficit) equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll and related liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current liabilities held for sale - discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, excluding current portion | ||||||||||||||||||||
| Operating lease liabilities, excluding current portion of $38,397 and $43,272 | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Noncurrent liabilities held for sale - discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| (Deficit) equity | ||||||||||||||||||||
| Common stock, par value $2 per share; authorized - 200,000 shares; issued and outstanding - 76,905 shares and 76,388 shares | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total deficit | ||||||||||||||||||||
| Total liabilities and deficit | ||||||||||||||||||||
Loading...
